Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
116.35
+4.35 (3.88%)
At close: Nov 18, 2026, 4:00 PM EST
119.87
+3.52 (3.03%)
Pre-market: Nov 19, 2026, 8:37 AM EST
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $7.93 billion as of November 18, 2026. It is the 2,479th most valuable company in the world and the 857th biggest in the United States. Its market cap has increased by 390.27% in one year.
Market Cap
7.93B
Enterprise Value
7.46B
1-Year Change
390.27%
Global Rank
Country Rank
#857 United States
Category
ChartMarket Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.50M to $7.93B, an increase of 2,029.55%. That is a compound annual growth rate of 46.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 7.93B | 308.98% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.84% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -39.79% |
| Dec 31, 2020 | 6.38B | 817.27% |
| Dec 31, 2019 | 695.50M | 7.78% |
| Dec 31, 2018 | 645.30M | 73.23% |
| Oct 31, 2018 | 372.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 7.21B |
| ABIVAX Société Anonyme | 7.04B |
| Immunovant | 6.89B |
| Oruka Therapeutics | 6.73B |
| Kodiak Sciences | 6.57B |
| Belite Bio | 6.55B |
| ImmunityBio | 6.36B |
| Arrowhead Pharmaceuticals | 6.25B |